Literature DB >> 18760592

Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.

Vincent Dancourt1, Catherine Lejeune, Côme Lepage, Marie Claude Gailliard, Bernard Meny, Jean Faivre.   

Abstract

The aim of this study was to compare the performance of a guaiac-based faecal occult blood test (G-FOBT) with that of an immunochemical faecal occult blood test (I-FOBT). A total of 17,215 average risk individuals aged 50 to 74 enrolled in a population-based organised screening programme and performed a 3-day G-FOBT and a 2-day I-FOBT simultaneously. Among participants, 3.1% were found positive for the G-FOBT and 6.9% for the I-FOBT (p<10(-4)). Among the 1205 participants who tested positive and underwent a colonoscopy, the number of detected cancers and advanced adenomas was respectively 2.6 times higher and 3.5 times higher with the I-FOBT than with the G-FOBT. The positive predictive value of I-FOBT was similar to that of the G-FOBT for cancers (5.9% versus 5.2%) and was higher for advanced adenomas (27.2% versus 17.5%). The I-FOBT was superior to the G-FOBT for the detection of both cancers and advanced adenomas. However, the screen positive rate that staff and financial resources can accommodate has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18760592     DOI: 10.1016/j.ejca.2008.06.041

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Cancer: What is the best screening test for colorectal cancer?

Authors:  Jean Faivre
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05       Impact factor: 46.802

2.  Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.

Authors:  Jessica Chubak; Andy Bogart; Sharon Fuller; Sharon S Laing; Beverly B Green
Journal:  Prev Med       Date:  2013-09-09       Impact factor: 4.018

3.  Similar fecal immunochemical test results in screening and referral colorectal cancer.

Authors:  Sietze T van Turenhout; Leo G M van Rossum; Frank A Oort; Robert J F Laheij; Anne F van Rijn; Jochim S Terhaar sive Droste; Paul Fockens; René W M van der Hulst; Anneke A Bouman; Jan B M J Jansen; Gerrit A Meijer; Evelien Dekker; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

4.  Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.

Authors:  Barcey T Levy; Camden Bay; Yinghui Xu; Jeanette M Daly; George Bergus; Jeffrey Dunkelberg; Carol Moss
Journal:  J Med Screen       Date:  2014-06-23       Impact factor: 2.136

5.  Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.

Authors:  Gary M Ginsberg; Stephen S Lim; Jeremy A Lauer; Benjamin P Johns; Cecilia R Sepulveda
Journal:  Cost Eff Resour Alloc       Date:  2010-03-17

6.  Cost-effectiveness of colorectal cancer screening - an overview.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

7.  Perspectives of colorectal cancer screening in Germany 2009.

Authors:  Andreas Sieg; Kilian Friedrich
Journal:  World J Gastrointest Endosc       Date:  2009-10-15

8.  Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy.

Authors:  Paolo Giorgi Rossi; Massimo Vicentini; Claudio Sacchettini; Enza Di Felice; Stefania Caroli; Francesca Ferrari; Lucia Mangone; Annamaria Pezzarossi; Francesca Roncaglia; Cinzia Campari; Romano Sassatelli; Roberto Sacchero; Giuliana Sereni; Luisa Paterlini; Marco Zappa
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

9.  Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing program.

Authors:  Jennifer A Schlichting; Michelle A Mengeling; Nader M Makki; Ashish Malhotra; Thorvardur R Halfdanarson; J Stacey Klutts; Barcey T Levy; Peter J Kaboli; Mary E Charlton
Journal:  J Community Health       Date:  2014-04

10.  Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.

Authors:  L Hol; J A Wilschut; M van Ballegooijen; A J van Vuuren; H van der Valk; J C I Y Reijerink; A C M van der Togt; E J Kuipers; J D F Habbema; M E van Leerdam
Journal:  Br J Cancer       Date:  2009-04-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.